CTRI/2019/06/019956已完成2 期
An open labelled non randomized Phase II comparative clinical trial to evaluate the therapeutic efficacy of SIDDHAR YOGAM THERAPY and Vilampazha karpam [ Siddha Kalpa Medicine-Internal] for Vatha Pitham [Hypertension]
Joshi0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Weight : 40-90 kgs
- •Normal level of lipid profile
- •Patients of Primary Hypertension having
- •BP Systolic 140-159 mm /Hg
- •BP Diastolic 90-99 mm /Hg
排除标准
- •Age group less than 30 and above 65
- •Secondary Hypertension
- •High risk pregnancy
- •Hypertension associated
- •CerebroVascular Accident (CVA)
- •Ischemic heart disease
- •Chronic Alcoholism
- •Chronic Liver Disease
- •Chronic Renal Disease (CRD)
- •Endocrine Disorder
- •Associated other secondary diseases like renal failure, CCF, other cardiac problems, chronic diseases, any hormonal disorders
- •Diabetes mellitus.
研究者
相似试验
已完成
2 期
CLINICAL TRIAL ON NEERIZHIVU[DIABETES MELLITUS] WITH YOGACTRI/2019/06/019749H JESIMA BARVEE40
已完成
2 期
Clinical trial on trial on eraippu erumal with yoga therapyCTRI/2019/06/019754S MUTHU VIGNESH40
已完成
2 期
TO EVALUATE THE THERAPEUTIC EFFICACY OF â??POTTANAMâ?? AS EXTERNAL THERAPY and SIDDHA POLYHERBAL FORMULATION â??AAYIL PATTAI CHOORANAMâ?? (INTERNAL) IN THE TREATMENT OF â??CEGANA VATHAMâ?? (CERVICAL SPONDYLOSIS)CTRI/2019/06/019936BKaruppannan40
进行中（未招募）
1 期
A phase 2 study evaluating S 95005 plus bevacizumab and capecitabine plus bevacizumab in patients with previously untreated colorectal cancer who are non-eligible for intensive therapyMetastatic colorectal cancerMedDRA version: 21.0Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004544-18-GBInstitut de Recherches Internationales Servier153
进行中（未招募）
1 期
A phase 2 study evaluating S 95005 plus bevacizumab and capecitabine plus bevacizumab in patients with previously untreated colorectal cancer who are non-eligible for intensive therapyMetastatic colorectal cancerMedDRA version: 19.1Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004544-18-NLInstitut de Recherches Internationales Servier150